📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. (2021)

First Author: Brown JWL

Attributed to: UK Dementias Platform funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(21)00179-4

PubMed Identifier: 34418398

Publication URI: http://europepmc.org/abstract/MED/34418398

Type: Journal Article/Review

Volume: 20

Parent Publication: The Lancet. Neurology

Issue: 9

ISSN: 1474-4422